North/western Europe (N=413) | Eastern Europe (n=30) | Southern Europe (N=193) | Total (N=636) | |
---|---|---|---|---|
General aspects of management | ||||
Non-pharmacological treatment | 5.8 (2.6) | 5.5 (2.9) | 6.7 (2.9)* | 6.0 (2.8) |
Pharmacological treatment | 4.9 (2.8) | 5.3 (2.6) | 6.4 (2.7)* | 5.4 (2.8) |
Diagnostic assessment | 4.7 (3.0) | 4.7 (2.9) | 6.9 (2.8)† | 5.3 (3.1) |
Practice organisation | 4.4 (2.8) | 5.6 (3.0) | 6.3 (2.7)* | 5.0 (2.9) |
Epidemiology | 5.1 (2.6) | 4.8 (2.7) | 6.1 (2.7)† | 5.4 (2.7) |
Teach the teacher | 4.8 (3.1) | 5.7 (3.4) | 6.6 (3.1)* | 5.4 (3.2) |
Rheumatic diseases to be addressed | ||||
Inflammatory arthritis | 6.0 (2.8) | 6.6 (3.4) | 7.6 (2.3)* | 6.5 (2.8) |
Osteoarthritis | 5.6 (2.7) | 6.0 (3.0) | 7.6 (2.4)† | 6.2 (2.8) |
Connective tissue diseases | 6.1 (2.6) | 6.5 (3.2) | 7.4 (2.4)* | 6.5 (2.7) |
Fibromyalgia | 5.7 (2.9) | 5.7 (2.7) | 7.8 (2.3)† | 6.3 (2.9) |
Low back pain | 5.3 (2.5) | 5.9 (2.7) | 7.6 (2.5)† | 6.0 (2.9) |
Osteoporosis | 5.6 (2.7) | 5.9 (3.1) | 7.2 (2.7)† | 6.1 (2.8) |
Preferred mode of delivery | ||||
Face-to-face course | 4.5 (3.2) | 4.2 (3.9) | 5.1 (3.3) | 4.6 (3.2) |
Face-to-face course with teach-the-teacher module | 4.0 (3.0) | 4.5 (3.6) | 5.1 (3.4)* | 4.3 (3.2) |
Practical workshop | 4.2 (3.3) | 5.9 (3.9) | 6.2 (3.4)* | 4.7 (3.4) |
Online course | 5.5 (3.1) | 5.4 (3.5) | 5.7 (3.5) | 5.7 (3.2) |
Preferred location of face-to-face course | ||||
Adjacent to EULAR Congress | 3.9 (3.1) | 3.9 (3.7) | 4.6 (3.3) | 4.1 (3.2) |
Easily accessible European city | 4.0 (3.0) | 4.9 (3.9) | 4.7 (3.5) | 4.2 (3.2) |
Own country | 5.5 (3.4) | 6.5 (3.8) | 6.0 (3.6) | 5.7 (3.5) |
Composition of participants | ||||
HPs‡ from own discipline | 5.9 (3.0) | 5.8 (3.5) | 6.6 (2.9)* | 6.1 (3.0) |
HPs from multiple disciplines | 5.7 (2.8) | 5.8 (3.4) | 7.1 (2.6)* | 6.1 (2.8) |
HPs from multiple disciplines including rheumatologists | 6.0 (2.9) | 6.6 (3.1) | 7.2 (2.6)* | 6.3 (2.9) |
*p<0.05, Analysis of variance, southern versus north/western European respondents, post hoc analysis.
†p<0.05, Analysis of variance, southern versus north/western and versus eastern European respondents, post hoc analysis.
‡HPs, health professionals.
EULAR, European League Against Rheumatism.